mb glp 1 activator GLP-ONE + Receptor GLP-1 MIND BODY by Life
Description
No significant increase in the risk of malignancy was observed
The samples were placed on dry ice until sampling was complete, then stored at 80 C until further processing
Feldman M, Schiller LR
This confounding makes it difficult to determine whether any observed risk is due to the medication or underlying patient characteristics
